COVID-19 — Coronavirus

Status
Not open for further replies.
PannickAtTheDisco said:
We need more information on how long it lasts. It sounds like you'll still have to isolate in some form between doses because it needs 2 doses to work?

Plus, I'd like them to be transparent and share their data on side effects, immune responses and organ function for each patient during the length of the trial.

Hopefully the positive talk translates into safe, measurable protection against the virus.
Click to expand...
Why would you need to self isolate between doses?
 
More a German/Turkish study than Pfizer, they simply are manufacturing it

FDA's mandates a threshold for a vaccine of at least 50% efficacy in placebo controlled trials so despite results of initial 94 patients, 90% is something to be excited about with the 2-dose trial vaccine in the Phase III analysis - importantly, no serious safety concerns yet noted

Promising preliminary results no question
 
Last edited:
PannickAtTheDisco said:
Of course, don't want to take that away from anyone.

On a side note, is it possible for them to identify the weakness in this vaccine that stops it being 100% effective and perhaps see if another vaccine, if they were teamed together, could cover all the bases? Or potentially at least say if you're from population x you need vaccine a, and population y you need vaccine b? One for those more well versed on these matters than myself.
Click to expand...
I’m on a vaccine trial and there was a discussion going at the last appointment as to what happens if another vaccine comes on the market sooner (this is due to finish trials November 2021). We were told the trial will continue as multiple vaccines will be needed and some may be more effective than others in different parts of society.
 
As an aside, I'd imagine such a news release had insider trading concerns in mind. Full disclosure will be in due course.
 
PannickAtTheDisco said:
We need more information on how long it lasts. It sounds like you'll still have to isolate in some form between doses because it needs 2 doses to work?

Plus, I'd like them to be transparent and share their data on side effects, immune responses and organ function for each patient during the length of the trial.

Hopefully the positive talk translates into safe, measurable protection against the virus.
Click to expand...
There was fourty odd thousand patients in the trial ! There is patient confidentality , the trial hasnt finished yet so published data will be later
 
PannickAtTheDisco said:
Of course, don't want to take that away from anyone.

On a side note, is it possible for them to identify the weakness in this vaccine that stops it being 100% effective and perhaps see if another vaccine, if they were teamed together, could cover all the bases? Or potentially at least say if you're from population x you need vaccine a, and population y you need vaccine b? One for those more well versed on these matters than myself.
Click to expand...

I don't know the answer to your question but 90% effectiveness is really high from what I've read. A lot of commentary on it was saying 70% would be a decent outcome. It's more effective than, for example, the TB vaccine which most people have happily been accepting of for years now.
 
somapop said:
What's the press conference about now?
Click to expand...
From The Guardian. The focus of this press conference is not yet known but there were reports in the weekend newspapers that Johnson is set to announce an expansion of the mass-testing pilot, which began in Liverpool on Friday, to other towns.

It has also been reported – for weeks, it has to be said – that the UK government is planning to reduce the length of time that people need to self-isolate from 10 or 14 days to seven.
 
Status
Not open for further replies.
Unread Posts

Don't have an account? Register now and see fewer ads!

SIGN UP
Back
Top